Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

Studies suggest that semaglutide reduces heart attack and stroke and may curb addiction and more. Scientists reflect on the future of GLP-1 drugs beyond weight loss.

With so many weight loss medications on the market, it's easy to feel overwhelmed by the options. From brand-name heavy ...

But in a twist this August, a separate part of North Carolina’s government allowed the Medicaid program to start covering the ...

Meds like Wegovy are all over the news. But are they right for you, especially if you’re older than the average user?

They are currently approved for treating diabetes, obesity and those with a history of cardiovascular disease in people who ...

Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medication as ...

Results from a recent survey have prompted questions about the influence of GLP-1s on the obesity rate of U.S. adults.

As demand for obesity drugs like Wegovy, Zepbound, Mounjaro and Ozempic, outpaces supply, online scams are rising, according ...

Novo Nordisk, the manufacturer of Ozempic and Wegovy, has petitioned the Food and Drug Administration (FDA) to add ...

More than 40 percent of Americans are now classified as obese while 75 percent of adults are either overweight or obese. A new group of drugs called GLP-1 receptor agonists have come on the scene to ...

The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.